eCite Digital Repository

Effect of a 4-week weight maintenance diet on circulating hormone levels: implications for clinical weight loss trials

Citation

Sainsbury, A and Evans, JR and Wood, RE and Seimon, RV and King, NA and Hills, AP and Byrne, NM, Effect of a 4-week weight maintenance diet on circulating hormone levels: implications for clinical weight loss trials, Clinical obesity, 5, (2) pp. 79-86. ISSN 1758-8103 (2015) [Refereed Article]

Copyright Statement

Copyright 2015 World Obesity

DOI: doi:10.1111/cob.12086

Abstract

The majority of weight loss studies fail to standardize conditions such as diet and exercise via a weight maintenance period prior to commencement of the trial. This study aimed to determine whether a weight stabilization period is necessary to establish stable baseline hormone concentrations. Fifty-one obese male participants with a body mass index of 30-40 kg m(-2) and aged 25-54 years underwent 4 weeks on an energy balance diet that was designed to achieve weight stability. Blood samples were collected in the fasting state at commencement and completion of the 4-week period, and circulating concentrations of 18 commonly measured hormones were determined. During the 4-week weight maintenance period, participants achieved weight stability within -1.5  0.2 kg (-1.4  0.2%) of their initial body weight. Significant reductions in serum insulin (by 18  6.5%) and leptin (by 21  6.0%) levels occurred, but no significant changes were observed for gut-derived appetite-regulating hormones (ghrelin and peptide YY), nor thyroid, adrenal, gonadal or somatotropic hormones. There were no significant correlations between the change in body weight and the change in circulating concentrations of insulin or leptin over the 4-week period, indicating that the observed changes were not due to weight loss, albeit significant negative correlations were observed between the changes in body weight and plasma ghrelin and peptide YY levels. This study demonstrates the need for baseline weight maintenance periods to stabilize serum levels of insulin and leptin in studies specifically investigating effects on these parameters in the obese. However, this does not apply to circulating levels of gut-derived appetite-regulating hormones (ghrelin and peptide YY), nor thyroid, adrenal, gonadal or somatotropic hormones.

Item Details

Item Type:Refereed Article
Keywords:Hormones; obesity; randomized controlled trial; run-in periods
Research Division:Medical and Health Sciences
Research Group:Nutrition and Dietetics
Research Field:Clinical and Sports Nutrition
Objective Division:Health
Objective Group:Public Health (excl. Specific Population Health)
Objective Field:Nutrition
Author:Hills, AP (Professor Andrew Hills)
Author:Byrne, NM (Professor Nuala Byrne)
ID Code:109154
Year Published:2015
Deposited By:Health Sciences
Deposited On:2016-05-30
Last Modified:2017-11-03
Downloads:0

Repository Staff Only: item control page